The United States and India launched their first joint drug policy working group in Washington last week, signaling deeper cooperation against narcotics trafficking.
The two-day meeting brought together top officials from both nations to combat what they called the growing threat of “narco-terrorism.”
The partnership comes as synthetic opioids continue devastating American communities while India grapples with chemical precursors flowing to drug cartels. Both countries pledged to dismantle trafficking networks while protecting legitimate pharmaceutical trade.
“The drug crisis is now a core national security priority,” said Sara Carter, Director of the Office of National Drug Control Policy, at the January 20-21 gathering. Carter emphasized President Trump and Prime Minister Modi’s commitment to strengthening security cooperation.
India’s Ambassador to the United States, Vinay Kwatra, echoed the urgency. He stated that India “accorded the highest priority to addressing the threat posed by narcotics trafficking and the diversion of precursor chemicals, while also balancing effective enforcement with facilitation of legitimate trade,” according to a White House press release.
The working group focused on delivering measurable outcomes for the counter-narcotics partnership. Acting Deputy Director Debbie Seguin led the U.S. delegation while Deputy Director General Monika Ashish Batra headed India’s team.
Both nations committed to a whole-of-government approach that streamlines efforts across agencies. They also pledged to secure pharmaceutical supply chains while respecting national regulations.
Recent joint operations have already disrupted trafficking networks, officials noted. The new framework aims to build on these successes through enhanced intelligence sharing and coordinated enforcement.
As synthetic drugs flood markets worldwide, traditional enforcement approaches have proven insufficient.
Officials from both countries emphasized protecting legitimate industries while cracking down on illegal operations. This balance reflects the complex nature of modern drug enforcement.
